CD5 negative diffuse mantle cell lymphoma with splenomegaly and bone marrow involvement

Southern Medical Journal

Volumn 91, Issue 6, 1998, Pages 584-587

  Bell, Norman D ^a,b   King, Judy A C ^a   Kusyk, Christine ^a   Nelson, Beverly P ^a   Sendelbach, Karla M ^a  

^a UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD5 ANTIGEN; CYCLOPHOSPHAMIDE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

AGED; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 11; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPH NODE BIOPSY; LYMPHADENOPATHY; LYMPHOCYTOSIS; MALE; MANTLE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; SPLENOMEGALY;

EID: 0031801867     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199806000-00016     Document Type: Article

References (19)

1. Bell N, King J, Sendelbach K: CD5 negative diffuse mantle cell lymphoma presenting with splenomegaly (Abstract). South Med J 1996; 89:S102-S103
2. Banks PM, Chan J, Cleary ML, et al.: Mantle cell lymphoma: a proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol 1992; 16:637-640
3. Weisenburger DD: Mantle cell lymphoma. Neoplastic Hematopathology. Knowles DM (ed). Baltimore, Williams & Wilkins Co, 1992, pp 617-627
4. Weisenburger DD, Duggan MS, Perry DA, et al.: Non-Hodgkin's lymphomas of mantle zone origin. Pathology Annual. Rosen P, Fechner RE (eds). Norwalk, Conn, Appleton Lange, 1990, pp 139-158
5. Frizzera G: Non-Hodgkin's lymphomas: pathologic features and clinical correlations. Hematology. Basic Principles and Practice. Hoffman R, Benz EJ, Sanford SS (eds). New York, Churchill Livingstone, 2nd Ed, 1995, pp 1247-1253
6. Lardelli P, Bookman MA, Sunden J, et al.: Lymphocytic lymphoma of intermediate differentiation. morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990; 14:752-763
7. Duggan MJ, Weisenburger DD, Ye YL, et al.: Mantle zone lymphoma. a clinicopathologic study of 22 cases. Cancer 1990; 66:522-529
8. Vandenberghe E: Mantle cell lymphoma. Blood Rev 1994; 8:79
9. Zukerberg LR, Medeiros LJL, Ferry JA, et al.: Diffuse low-grade B-cell lymphomas: four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 1993; 100:373-385
10. Harris NL, Nadler LM, Bhan AK: Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies: follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities. Am J Pathol 1984; 117:262-272
11. Heim S, Mitelman F: Cancer Cytogenetics. New York, Wiley-Liss, 2nd Ed, 1995, pp 285-286
12. Williams ME, Swerdlow SH, Rosenberg CL, et al.: Chromosome 11 translocation breakpoints at the PRAD 1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia 1993; 7:241-245
13. Rimokh R, Berger F, Delsol G, et al.: Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 1994; 83:1871-1875
14. Swerdlow SH, Yang W, Zukerberg LR, et al.: Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the bcl-1/cyclin D1 gene. Hum Pathol 1995; 26:999-1004
15. Gaidano G, Hauptschein RS, Parsa NZ, et al.: Deletions involving two distinct regions of 6q in B-cell non-Hodgkin's lymphoma. Blood 1992; 80:1781-1787
16. Yatabe Y, Nakamura S, Seto M, et al.: Clinicopathologic study of PRAD1/cyclin D1 over expressing lymphomas with special reference to mantle cell lymphoma. a distinct molecular pathologic entity. Am J Surg Pathol 1996; 20:1110-1122
17. Jandl JH: Non-Hodgkin's lymphoma. Blood. Textbook of Hematology. Jandl JH (ed). Boston, Little Brown and Co, 2nd Ed, 1996, pp 1137-1194
18. Weiss LM, Chan CW, Schnitzer B: Lymph nodes. Anderson's Pathology. St. Louis, CV Mosby Co, 10th Ed, 1996, pp 1170-1171
19. Segal GH, Masih AS, Allyson CF, et al.: CD-5 expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogenous immunophenotype and are associated with an overall poor prognosis. Blood 1995; 85:1570-1579